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Passive targeting of lipid-based nanoparticles
to mouse cardiac ischemia–reperfusion injury
Tessa Geelen, Leonie E. Paulis, Bram F. Coolen, Klaas Nicolay and
Gustav J. Strijkers*
Reperfusion therapy is commonly applied after a myocardial infarction. Reperfusion, however, causes secondary
damage. An emerging approach for treatment of ischemia–reperfusion (IR) injury involves the delivery of therapeutic
nanoparticles to the myocardium to promote cell survival and constructively inﬂuence scar formation and myocardial
remodeling. The aim of this study was to provide detailed understanding of the in vivo accumulation and distribution
kinetics of lipid-based nanoparticles (micelles and liposomes) in a mouse model of acute and chronic IR injury. Both
micelles and liposomes contained paramagnetic and ﬂuorescent lipids and could therefore be visualized with magnetic
resonance imaging (MRI) and confocal laser scanning microscopy (CLSM). In acute IR injury both types of nanoparticles
accumulated massively and speciﬁcally in the infarcted myocardium as revealed by MRI and CLSM. Micelles displayed
faster accumulation kinetics, probably owing to their smaller size. Liposomes occasionally co-localized with vessels
and inﬂammatory cells. In chronic IR injury only minor accumulation of micelles was observed with MRI. Nevertheless,
CLSM revealed speciﬁc accumulation of both micelles and liposomes in the infarct area 3h after administration. Owing
to their speciﬁc accumulation in the infarcted myocardium, lipid-based micelles and liposomes are promising vehicles
for (visualization of) drug delivery in myocardial infarction. Copyright © 2012 John Wiley & Sons, Ltd.
Supporting information may be found in the online version of this paper
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1. INTRODUCTION
The best treatment option for acute myocardial infarction is
currently early reperfusion of the affected myocardium. The aim
of restoring blood ﬂow is to limit the extent of myocardial necrosis
and scarring, which are important factors in the development of
systolic heart failure and determine prognosis. The downside
of reperfusion treatment is that it causes adverse secondary
ischemia–reperfusion (IR) injury by the generation of cytotoxic
reactive oxygen species, resulting in additional apoptosis (1). After
the initial IR event a dynamic cascade of events is initiated to
promote myocardial infarct healing. In the acute phase, early after
the ischemic event, infarct healing is characterized by cell death
and inﬂammation. At later time points, in the chronic phase, the
affected myocardium remodels into scar tissue (2–5).
An emerging approach for further treatment of IR injury
involves the delivery of therapeutic compounds to the myocar-
dium to promote cell survival and constructively inﬂuence scar
formation and myocardial remodeling (6,7). The effectiveness
of intravenously injected therapeutics may be hampered by fast
clearance from the blood circulation and by lack of retention in
the infarcted myocardium. To improve drug delivery to the
infarct, nanoparticles offer a suitable vehicle as they can be
designed to display long blood circulation half-lives and are able
to encapsulate a large amount of drug molecules. Furthermore,
owing to their size, nanoparticles demonstrate prolonged
retention in the infarct area, which is enabled by the presence
of leaky vasculature (8,9). Previously, liposomal nanoparticles
were exploited for such purposes. Injection of ATP-, coenzyme
Q10-, PGE1- or adenosine-loaded liposomes resulted in a
reduction of the extent of irreversibly damaged myocardium
within the area at risk (10–15). Furthermore, accumulation of
pegylated micelles in the infarcted myocardium has been
demonstrated in a rabbit model of myocardial infarction (16).
Therefore, micelles were proposed for delivery of lipophilic drugs
(16,17). The above studies have in common that information on
accumulation kinetics in the heart was lacking and the exact
location of the lipid-based nanoparticles at cellular scale was
not visualized. Obviously, these need to be determined for
optimization of drug delivery. Furthermore, only acute IR injury
(up to 3 h reperfusion time) was considered, which is clinically
less relevant, and therefore later time points after IR injury
should be studied as well.
Therefore, the aim of this study was to provide detailed under-
standing of the in vivo accumulation and distribution kinetics of
long-circulating lipid-based nanoparticles in a mouse model of
acute (1 day old) as well as chronic (up to 2weeks) myocardial
IR injury. We studied micelles (diameter approximately 15 nm)
and liposomes (diameter approximately 100 nm) to investigate
inﬂuence of nanoparticle size. Both micelles and liposomes were
equipped with paramagnetic Gd-containing lipids and with
ﬂuorescent lipids. Importantly, this enabled us to study the
distribution of the nanoparticles in the infarcted myocardium
in vivo using MRI, as well as to localize the nanoparticles at the
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cellular level ex vivo with confocal laser scanning microscopy
(CLSM). As a control late gadolinium enhancement (LGE) MRI
was performed after administration of Gd–DTPA. Furthermore,
contrast-enhanced in vivo MRI was complemented with cine
MRI to determine cardiac function.
2. RESULTS AND DISCUSSION
2.1. Nanoparticle Characterization
Micelles and liposomes were ﬁrst characterized with respect to
hydrodynamic size and MRI relaxivity properties at 1.41 and
9.4 T (Table 1). Gd–DTPA was included as a reference. Micelle
diameter was approximately 15 nm and the liposome diameter
of 100 nm was signiﬁcantly larger. At 1.41 T, the micelle and
liposome longitudinal relaxivity (r1) values were higher than
those for Gd–DTPA. Thus, the nanoparticles are powerful MRI
contrast agents, which is further ampliﬁed by the high payload
of Gd–DOTA-carrying lipids incorporated in the lipid membranes.
As expected, at 9.4 T, r1 values were considerably lower compared
with 1.41 T (18). Nevertheless, the r1 of micelles was still higher
than the r1 of Gd–DTPA. The ratio of transversal and longitudinal
relaxivities (r2/r1) of both micelles and liposomes was relatively
high at 9.4 T, indicating that the nanoparticles will display a
pronounced T2 shortening effect at high ﬁeld strengths. From
the relaxivity data we concluded that the nanoparticles possessed
ample sensitivity for in vivoMR imaging of nanoparticle accumula-
tion in cardiac IR injury.
2.2. Blood Circulation Half-lives and Biodistribution
To investigate the blood circulation half-lives and biodistribution,
mice were injected with Gd–DTPA, micelles or liposomes and
blood samples were obtained up to 48h after administration.
Blood ΔR1 values (= 1/T1,post  1/T1,pre) determined at 9.4 T served
as a measure of the concentration of nanoparticles in the circula-
tion (Fig. 1a) (19). Frommono-exponential ﬁts the blood circulation
half-lives were calculated (Fig. 1a). As expected, Gd–DTPA had a
short blood circulation half-life of 0.30 0.05 h owing to fast renal
clearance enabled by its small size. Micelles and liposomes
displayed relatively long blood circulation half-lives of 3.90 0.44
and 2.31 0.40 h, respectively. Previously, van Bochove et al.
observed longer blood circulation half-lives in mice for micelles
(22.5 2.8h) and liposomes (7.0 1.0h) containing neutral
Gd–DTPA-carrying lipids (20). The Gd–DOTA-conjugated lipids
used in this study have a charge of 1, which could induce faster
blood clearance via ingestion by phagocytic cells (21).
To determine the in vivo fate of micelles and liposomes, animals
were killed 48h after administration of the nanoparticles. Organs
were excised and the biodistribution was studied with CLSM
(Fig. 1b). Micelles accumulated mainly in the kidney, suggesting
a clearance pathway that partly involved renal elimination.
Liposomes were mainly detected in the spleen and in smaller
amounts in the liver, lungs and kidneys. The large size of liposomes
prohibits renal clearance and therefore it is likely that they are
removed from the blood by the reticuloendothelial system.
2.3. In Vivo MRI
Mice underwent transient occlusion (30min) of the left anterior
descending (LAD) coronary artery to induce cardiac IR injury.
Contrast-enhanced in vivo MRI was performed at day 1 (acute), or
at week 1 or week 2 (chronic) after IR injury to visualize the
distribution and extravasation kinetics of Gd–DTPA, micelles and
liposomes. The MRI protocol is depicted schematically in Fig. 2.
Table 1. Characterization of Gd–DTPA, micelles and liposomes
Hydro-dynamic
diameter (nm)
r1 (mM
1 s1) at
1.41 T, 37 C
r2 (mM
1 s1) at
1.41 T, 37 C
r2/r1 at
1.41 T, 37 C
r1 (mM
1 s1) at
9.4 T, 20 C
r2 (mM
1 s1) at
9.4 T, 20 C
r2/r1 at
9.4 T, 20 C
Gd–DTPA ND 3.3 0.2 3.7 0.3 1.14 0.01 3.9a 4.2a 1.1a
Micelles 15.6 0.2 29.7 1.4 45.9 1.0 1.55 0.05 6.3 0.3 51.5 2.2 8.1 0.1
Liposomes 100.1 3.6* 14.1 0.7* 22.2 1.0* 1.58 0.01 3.2 0.1* 56.7 3.0 17.9 0.3*
Mean standard error of the mean (n=3), except: a n= 1. * p< 0.05 vs micelles.
Figure 1. Blood circulation half-lives and biodistribution. (a) ΔR1 (=1/T1,post 1/T1,pre) of all blood samples, as measured at 9.4 T, plotted vs time after
injection. Blood circulation half-lives were determined by ﬁtting with a mono-exponential decay function (solid lines), leading to the blood circulation
half-lives (t1/2) as shown in the table (Mean SD). (b) Biodistribution of nanoparticles in several organs. The red color originates from the near-infrared
(NIR) signal of micelles and liposomes. As a non-ﬂuorescent negative control, organs from mice injected with Gd–DTPA are shown. Scale bar = 100mm.
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In addition, cine MRI was performed to determine cardiac
function. Myocardial IR injury resulted in a similar reduction in
cardiac function at all investigated time points (Supporting
Information, Fig. S1). Ejection fractions (EF) were 52 2, 54 3
and 59 4% at day 1, week 1 and week 2, respectively, which
are lower than EF values reported for healthy mice (70–80%),
conﬁrming the presence of myocardial infarction (22,23). Relatively
high standard deviations in EF suggested heterogeneous infarct
sizes within groups. Cardiac output (CO) and the left ventricular
mass were signiﬁcantly higher at week 1 and week 2 as compared
with day 1, which can be explained by left ventricular remodeling
after IR injury.
2.4. Acute IR Injury – Day 1
Gd–DTPA, micelles or liposomes were injected immediately or at
day 1 after induction of IR injury. For both groups the accumula-
tion of Gd–DTPA and paramagnetic nanoparticles was visualized
by T1-weighted short-axis multi-slice MRI at day 1 after the IR
injury. Injection of Gd–DTPA at day 1 resulted in immediate
hyperenhancement of the infarcted myocardium (Fig. 3a). The
hyperenhancement slowly disappeared within the next 30min,
in agreement with the extensively described LGE effect used to
measure infarct size (24). The contrast-to-noise ratio (CNR) of
infarct versus remote tissue at 0.1 h after administration (Fig. 3b)
was signiﬁcantly enhanced compared with CNRs pre injection
and at later time points (46.9 3.7, p< 0.05 vs all time points).
No residual contrast enhancement was observed at day 1 when
Gd–DTPA was injected directly after IR injury and circulated for
24 h. As a negative control for the ﬂuorescence microscopy
analysis of hearts from nanoparticle-injected mice, CLSM of mouse
hearts injected with Gd–DTPA was performed. As expected, no
near-infrared (NIR) autoﬂuorescence was observed (Fig. 4).
In contrast to the observations for Gd–DTPA, administration of
nanoparticles at day 1 resulted in hyperenhancement of remote
cardiac tissue at 0.1h after injection, while the infarct area
remained isointense and, therefore, appeared as a dark rim (Fig. 3a).
Consequently, the CNR of infarct versus remote tissue at 0.1 h was
negative, amounting to 11.7 1.4 and 9.3 3.1 for micelles
and liposomes, respectively (Fig. 3b). At this early time point after
administration micelles and liposomes were still circulating in the
blood, while accumulation into infarcted myocardium might not
be present yet. We propose that the absence of signal intensity
changes in the infarct reﬂected the impaired perfusion of the
infarct. Often the dark rim of infarct tissue was present in the
subendocardium. Indeed, the subendocardium is most prone
to IR injury as it is located most distal from the coronary
arteries (25,26). These observations suggest that the lipid-based
Figure 2. In vivo MRI protocol. T1-weighted scans were acquired in all sessions to investigate accumulation of Gd–DTPA, micelles or liposomes in
myocardial tissue up to 48h after injection. During the last imaging session of a series cine MRI scans were recorded as well, to evaluate cardiac function.
Arrows indicate the time point of injection of Gd–DTPA, micelles or liposomes. In the chronic ischemia–reperfusion (IR) injury groups, one mouse was killed
after 3h of circulation ofmicelles or liposomes (day 6/13) for histology, while the othermicewere followed up to 48h after injection. IR, Ischemia–reperfusion
surgery; &, cine MRI; and †, sacriﬁce and tissue harvesting for histological validation.
Figure 3. In vivo MRI of acute IR injury. (a) Short-axis T1-weighted MR images obtained before and after injection of Gd–DTPA (row 1), micelles (row 2)
or liposomes (row 3). In columns 1–3, the agents were injected on day 1 after IR injury, while in column 4 the agents were administered at the start of
reperfusion and circulated for 24 h. Arrows indicate the areas of contrast enhancement. (b) Group-averaged CNRs between infarct and remote tissue at
different time points after injection. * p< 0.05 vs all time points; ** p< 0.05 vs pre; † p< 0.05 vs 0.1 h after injection; †† p< 0.05 vs all contrast agents at
1.4 h after injection; and { p< 0.05 vs Gd–DTPA at 24 h after injection.
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nanoparticles may offer a surrogate diagnostic readout, as a
blood-pool agent, of the viable and perfused myocardium.
Nevertheless, for the determination of myocardial infarct size
traditional LGE MRI with Gd–DTPA is still the method of choice.
After 1.4 h, micelle accumulation in the infarct area became
apparent resulting in disappearance of the dark rim in the infarct
area (Fig. 3). The CNR increased signiﬁcantly to a positive value
of 6.9 5.4 (p< 0.05 vs 0.1 h). For the larger liposomes, the
T1-weighted signal increase proceeded more slowly. The suben-
docardial infarct remained hypoenhanced at this time point and
this resulted in a persistent negative CNR of 4.0 2.4. CLSM
was used to detect the NIR lipid present in the micelles and
liposomes to determine nanoparticle localization at the cellular
level. For this purpose, short-axis histological sections of multiple
mice at multiple longitudinal positions and multiple locations
in the infarct, in the border zone and in the remote myocardium
were studied. CLSM of hearts at 3 h after injection conﬁrmed
extensive accumulation of micelles in the infarcted myocar-
dium (Fig. 4, Table 2). Accumulation was high in the infarct
border zones and in the core of the infarcted myocardium. NIR
signal of micelles did not co-localize with inﬂammatory cells or
vessels. Staining of laminin (extracellular matrix) revealed that
micelles were primarily associated with infarcted cardiomyocytes.
Liposomes, on the other hand, were present in distinct spots in
the infarct border zone area and occasionally co-localized with
macrophages, indicating phagocytosis.
After 24 h of circulation (Fig. 3), both micelles and liposomes
had accumulated in the infarcted myocardium and caused
Figure 4. Confocal laser scanning microscopy (CLSM) of infarcted myocardium and border zones at day 1 after IR injury. Images were acquired after short
(3h) or after long (24h) circulation of the nanoparticles. In all images the ﬂuorescence of NIR lipids incorporated inmicelles and liposomes is shown in red. As
a ﬂuorescence-negative control, mice injected with Gd–DTPA are shown. Scale bar = 100mm. Row 1: green corresponds to autoﬂuorescence of the heart.
Autoﬂuorescence is less intense in the infarcted myocardium. Laser intensities for NIR visualization are given as percentages of the maximal laser intensity.
For NIR visualization after staining, this laser intensity was always set to 50%. Row 2: leukocytes (CD18+) in blue; row 3: macrophages (CD68+) in green; row 4:
vessels (CD31+) in blue; and row 5: laminin in green.
Table 2. Visual scoring of confocal laser scanning microscopy
images for intensity of near-infrared ﬂuorescence signal
intensities after acute ischemia–reperfusion injury
Time after
administration nanoparticle Remote Border zone Infarct
3 h Gd–DTPA   
Micelles  + ++
Liposomes  + 
24 h Gd–DTPA   
Micelles   ++
Liposomes  + ++
 = No;= low;=moderate; + = high; and ++= very high
near-infrared ﬂuorescence signal intensity.
T. GEELEN ET AL.
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hyperenhancement compared with the remote myocardium
with signiﬁcantly enhanced CNR values of 24.0 5.2 and
19.9 2.9 for micelles and liposomes, respectively (p< 0.05 vs
pre and vs Gd–DTPA at 24 h). CLSM at 24 h revealed that micelles
had accumulated diffusively and very speciﬁcally in the infarcted
myocardium, which is in agreement with MRI (Fig. 4, Table 2).
Liposomes had extravasated after 24 h of circulation and were
massively associated with the infarcted myocardium, although
the accumulation pattern appeared more scattered compared
with micelles. Immunohistochemistry demonstrated that part
of the liposomes was still present in vessels, probably owing
to their long blood circulation half-lives. Some NIR signal of
liposomes co-localized with leukocytes, while macrophages were
almost absent. Staining of laminin revealed that most liposomes
were present inside cells, most probably cardiomyocytes.
2.5. Chronic IR Injury – Weeks 1 and 2
LGE MRI with Gd–DTPA resulted in hyperenhancement of chronic
infarcts at 0.1 h after injection (Fig. 5a, c). At this time point after
administration CNR values were 24.3 1.1 and 25.4 5.8 at
weeks 1 and 2, respectively (p< 0.05 vs all time points, Fig. 5b, d).
Owing to fast washout, Gd–DTPA enhancement was absent at
later time points.
Injection of micelles at week 1 resulted in immediate hyperen-
hancement of the remote tissue on T1-weighted MRI, again with
an isointense subendocardial infarct, consequently appearing as
a dark rim. CNR of the infarct with remote tissue was 6.3 1.9
(Fig. 5a, b). Thereafter, micelles accumulated in the infarct resulting
in CNR values of 5.3 1.9, 5.6 3.4 and 3.6 2.2 formeasurements
at 1.4, 24 and 48h after administration (p< 0.05 vs 0.1 h). After
short circulation of the nanoparticles (3 h), CLSM revealed diffuse
accumulation of micelles in the infarcted myocardium, which
sometimes co-localized with inﬂammatory cells (Figs 6 and 7).
Some remaining NIR ﬂuorescence was observed in scattered spots
48h after administration. However, these ﬂuorescent spots were
also present in mice injected with Gd–DTPA and are related to
autoﬂuorescence of inﬂammatory cells. Liposome injection at
week 1 resulted in a (small) hypoenhancement of the infarct at
0.1 h and slight hyperenhancement at the later time points.
However, group-averaged CNR values for liposome-injected
animals were not signiﬁcantly different from pre-injection values
(Fig. 5a, b). Remarkably, CLSM showed accumulation of liposomes
in the infarcted myocardium 3h after administration, which
sometimes co-localized with macrophages (Figs 6 and 7). At 48h
after administration fewer spots remained.
Administration of micelles or liposomes at week 2 after IR injury
did not result in visible hypo- or hyperenhancement onMR images
Figure 5. In vivoMRI of chronic IR injury. (a) Short-axis T1-weightedMR images obtained before and after injection of Gd–DTPA (row 1), micelles (row 2) and
liposomes (row 3) at week 1 after IR injury. (b) Group-averaged CNRs between infarct and remote tissue at different time points after injection. * p< 0.05 vs all
time points; † p< 0.05 vs 1.4h after injection; and †† p< 0.05 vs all contrast agents at 0.1h after injection. (c) MRI at week 2 after IR injury before and after
injection of Gd–DTPA (row 1), micelles (row 2) and liposomes (row 3). (b) Group-averaged contrast-to-noise ratios between infarct and remote tissue at
different time points after injection. * p< 0.05 vs all time points and †† p< 0.05 vs all contrast agents at 0.1h after injection.
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or in changes in quantiﬁed CNR values (p> 0.05 vs all).
Two weeks after IR injury the infarcted myocardium is mainly
replaced by ﬁbrotic tissue, in which only few vessels are present.
This will hamper extravasation and accumulation of the large
nanoparticles in the infarct. With CLSM diffuse accumulation of
micelles and scattered spots of liposomes NIR ﬂuorescence were
observed in the infarcted myocardium at the early time point
after injection (3h), whereas some of the ﬂuorescence remained
at 48 h for both nanoparticles (Fig. 6).
2.6. Implications
Micelles and particularly liposomes have extensively been
studied and applied as drug carriers, mainly for oncological
Figure 6. CLSM of infarcted myocardium and border zones at week 1 and 2 after IR injury. Images were acquired after short (3h) or after long (48h)
circulation of the nanoparticles. NIR ﬂuorescence of micelles and liposomes is shown in red. Green corresponds to autoﬂuorescence of the heart. Autoﬂuor-
escence is less intense in the infarcted myocardium. Laser intensities are given as percentages of the maximal laser intensity. As a negative control, mice
injected with Gd–DTPA are shown. Scale bar=100mm.
Figure 7. CLSM of infarcted myocardium at week 1 and 2 after IR injury. All images were obtained after 3h circulation of the nanoparticles. Fluorescence of
NIR-lipids incorporated in micelles and liposomes is shown in red and 50% laser intensity was used. Scale bar=100mm. Row 1: leukocytes (CD18+) in blue;
row 2: macrophages (CD68+) in green; row 3: vessels (CD31+) in blue; and row 4: laminin in green.
T. GEELEN ET AL.
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purposes (27,28). Cardiotoxicity, a well-known side effect of
several cytotoxic anti-tumor drugs, for example, doxorubicin, can
be diminished by encapsulation of the therapeutics (29,30). When
the diseased myocardium is the target, micelles and liposomes
offer a suitable platform for drug delivery as well. As indicated
before, encapsulation of therapeutic compounds in liposomes
resulted in a reduction of infarct area. Furthermore, encapsulation
of the therapeutics had the advantage of preventing drug
degradation (10,11), diminishing or even preventing adverse side
effects (13,14) and overcoming poor drug solubility (15).
In this study we showed that micelles and liposomes, over a
time period of 24h, accumulated very speciﬁcally in the acute IR
injured myocardium. Importantly, in our study little to no accumu-
lation of micelles and liposomes was observed in the healthy
remote myocardium, indicating speciﬁc delivery of the nanoparti-
cles to infarcted myocardium. Whereas micelles associated with
the cardiomyocytes, liposomes were found more scattered in
the tissue and were associated with vessels, inﬂammatory cells
or cardiomyocytes, rendering both nanoparticles suitable for
targeting different aspects of ischemic injury in the acute phase.
Also in the chronic phase, when the infarct is characterized by
extensive ﬁbrosis, micelles and liposomes were accumulating,
although to a lesser extent, in the infarcted myocardium 3h after
administration. Therefore, these nanoparticles are suitable for
drug delivery purposes in chronic infarction as well, for example,
to prevent further adverse remodeling of the scar and reduce
the risk of heart failure.
In this study semi-quantitative T1-weighted MRI was used to
study the accumulation of paramagnetic nanoparticles in the
infarcted myocardium. Future studies may focus on the in vivo
estimation of local nanoparticle concentration by the application
of quantitative T1 mapping (31,32). In future drug delivery
studies this could result in the quantiﬁcation of delivery of the
carrier to the infarcted myocardium, as a measure of local drug
delivery, which can be related to the observed therapeutic effect.
Although we have shown that passive targeting of micelles
and liposomes to the infarct is very speciﬁc, there may be an
additional beneﬁt of an active targeting approach. Verma et al.
showed that non-targeted ATP-containing liposomes diminished
IR injury. However, targeting of the ATP-containing liposomes to
myosin resulted in almost complete recovery of cardiac function
(33). Therapy with VEGF-loaded liposomes targeted against
myosin resulted in improved cardiac function, while this was
not observed for non-targeted VEGF-liposomes (34). Incorporation
of phosphatidylserine in the lipid membrane of liposomes for
macrophage targeting resulted in diminished left ventricular
remodeling in a permanent ligation model of myocardial
infarction (35). The micelles and liposomes in the current study
can be made target speciﬁc straightforwardly by incorporation of
different lipids in the lipid membrane or by conjugation of ligands
to the distal ends of polyethylene glycol (PEG) chains. Previously,
such nanoparticles were used for MR imaging of angiogenesis
and apoptosis (36–38).
3. CONCLUSIONS
In this study the extravasation and accumulation properties of
paramagnetic micelles and liposomes in mouse myocardial IR
injury were studied with MRI and CLSM. Micelles and liposomes
accumulated massively and speciﬁcally in the acute infarcted
myocardium. Micelles displayed faster accumulation kinetics
compared with liposomes, presumably owing to their smaller
size. In 1- and 2-week-old chronic infarcts, micelle and liposome
accumulation was less but still detectable 3 h after administration.
Because the nanoparticles generated signiﬁcant contrast in MRI
they are suitable for combined imaging and therapy. Altogether,
we conclude that the presented lipid-based nanoparticles are
promising vehicles for drug targeting purposes in myocardial
infarction.
4. EXPERIMENTAL
4.1. Nanoparticle Preparation and Characterization
Micelles were prepared by lipid ﬁlm hydration of a lipid mixture
containing 50mmol of total lipid. The lipid mixture consisted of
gadolinium–DOTA-1,2-distearoyl-sn-glycero-3-phospoethanolamine
(Gd–DOTA–DSPE, SyMO-Chem BV, Eindhoven, the Netherlands),
1,2-distearoyl-sn-glycero-3-phospoethanolamine-N-{methoxy
[poly(ethylene glycol)]-2000} (PEG2000–DSPE, Lipoid, Ludwig-
shafen, Germany) and 1,2-distearoyl-sn-glycero-3-phospoethano-
lamine-N-{maleimide[poly(ethylene glycol)]-2000} (Mal-PEG2000–
DSPE, Avanti Polar Lipids, Alabaster, AL, USA) at a molar ratio
of 0.5:0.4:0.1 and was dissolved in chloroform:methanol 4:1
(v/v). Next, 1mol% of near-infrared664-1,2-distearoyl-sn-glycero-3-
phospoethanolamine (NIR664–DSPE, SyMO-Chem BV) was added.
Solvents were removed by rotary evaporation at 30 C and the
resulting lipid ﬁlm was dried overnight under a constant nitrogen
ﬂow. The lipid ﬁlm was dissolved in HEPES buffered saline
(HBS, 10mM HEPES, 135mM NaCl, pH 6.7) and stirred at 65 C for
1 h. Finally, the micelles were concentrated using a Vivaspin
concentrator (20ml, MWCO 100 000Da, 3000 rpm) and resus-
pended in HBS (pH 7.4) at a concentration of approximately
35mM lipid.
Liposomes were prepared as described earlier by lipid ﬁlm
hydration of a lipid mixture (21). Brieﬂy, the lipid mixture (50mmol
of total lipid) consisting of Gd–DOTA–DSPE, 2-distearoyl-sn-
glycero-3-phosphocholine (Lipoid), cholesterol (Avanti Polar
Lipids), PEG2000–DSPE and Mal-PEG2000–DSPE was dissolved
at a molar ratio of 0.75:1.1:1:0.075:0.075 in chloroform–methanol,
8:1 (v/v). Additionally, 0.1mol% NIR664–DSPE was incorporated.
After rotary evaporation at 30 C and overnight drying under a
nitrogen ﬂow, the lipid ﬁlm was hydrated in HBS (pH 6.7). The
resulting particles were sized by extrusion through 400nm ﬁlters
(twice), 200 nm ﬁlters (four times) and 100nm ﬁlters (eight times).
Finally, the liposomes were concentrated using ultracentrifugation
(45min, 55 000 rpm, 4 C) and resuspended in HBS (pH 7.4) at a
concentration of approximately 70mM lipid.
The ﬁnal lipid concentrations of micelles and liposomes were
measured by a phosphate determination according to Rouser
(39). Number-weighted hydrodynamic size and size distribution
were assessed with dynamic light scattering (ZetaSizer NanoS,
Malvern Instruments Ltd, Malvern, UK) at 23 C.
Longitudinal and transversal relaxivities r1 and r2 of micelles and
liposomes were measured in HBS solution (pH 7.4). Values for r1
and r2 are reported in mM
1 s1. High-ﬁeld relaxivities were
measured at 9.4 T and room temperature with a small animal MR
scanner (Bruker BioSpin GmbH, Ettlingen, Germany). For T1
measurements an inversion recovery fast low angle shot (FLASH)
sequence was used, with the following parameters: overall
repetition time (TR) 15 s, TR 4ms, echo time (TE) 2ms, ﬂip
angle (a) 15 , number of excitations (NEX) 4, ﬁeld of view
(FOV) 3 3 cm2, matrix 128 128, 1mm slice thickness, 32
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segments and 60 inversion times ranging from 72.5 to 4792.5ms.
T2 relaxation times were determined using a multi-slice multi-echo
sequence with the following parameters: TR 2000ms, 32 echo
times ranging from 9 to 288ms, a 180, NEX 4, FOV 3 3 cm2,
matrix 128 128 and 1mm slice thickness. Low-ﬁeld relaxivities
were determined at 1.41 T and 37 C with a Bruker Minispec
(Bruker BioSpin GmbH). T1 values were measured using an inversion
recovery sequence, with the following parameters: recycle delay
20 s, 10 inversion times ranging from 5ms to 10 s and four averages.
T2 values were determined with a CPMG sequence, with: recycle
delay 20 s, inter-echo time 0.4ms, 10 000 echoes and 16 averages.
4.2. Blood Circulation Half-lives and Biodistribution
All animal experiments were performed in accordance with the
declaration of Helsinki and were approved by the local ethical
committee for animal experiments of University of Maastricht.
To determine blood kinetics, healthy Swiss mice (n=3/group,
35.6 1.1 g, Charles River Laboratories, Sulzfeld, Germany) were
injected intravenously with Gd–DTPA (0.3mmol Gd kg1 body
weight (b.w.), Bayer HealthCare Pharmaceuticals, Mijdrecht, the
Netherlands), micelles (0.05mmol Gd kg1 b.w.) or liposomes
(0.05mmol Gd kg1 b.w.). Before and at different time points
after injection (2, 15, 30, 45 and 60min and 4, 8, 24 and 48 h),
blood samples of 20ml were taken from the vena saphena and
diluted in 20ml heparinized saline to prevent coagulation. T1
relaxation times were measured at 9.4 T using the same inversion
recovery FLASH sequence as described above. For further study
of the biodistribution of the nanoparticles, mice were killed by
cervical dislocation after the last blood sample (48 h) and organs
were excised, frozen in melting isopentane and cryosections of
5mm were prepared.
4.3. In Vivo Cardiac MRI
Cardiac IR injury was induced in n=49male Swissmice (35.3 0.4g,
Charles River Laboratories). First, mice were anesthetized with 3%
isoﬂurane in 0.4mlmin1 medical air and anesthesia was main-
tained using 1.5–2.5% isoﬂurane. Next, mice underwent transient
(30min) ligation of the LAD coronary artery. Ligation of the LAD
coronary artery was conﬁrmed by blanching of the myocardium.
After waking up, mice were kept overnight in a recovery room
at 30 C.
Micelles or liposomes were injected intravenously via a tail
vein catheter at a dose of 0.05mmol Gd kg1 b.w. As a control,
mice were injected with Gd–DTPA (0.3mmol Gd kg1 b.w.).
Administration of the agents was performed either at the start of
reperfusion, or at day 1, week 1 or week 2 after the start of reperfu-
sion (n=3-5/group, for details see Supporting Information, Table
S1, and Fig. 2). Animals were randomly assigned to one of these
groups before IR injury. Cardiac MRI was performed before and
up to 48h after administration of the contrast agents. To prevent
the inﬂuence of differences in infarct composition during the
experimental protocol, the day 1 groups were followed up to
24h after injection only. For in vivo MRI, anesthesia was induced
with 3% isoﬂurane in 0.4 Lmin1 medical air and maintained with
1.5–2.5% isoﬂurane. Mice were positioned supine in a custom-built
animal-holder with a heating pad and the ECG, breathing rate
and temperature were monitored. The cardiac rate was kept at
400–600 beats per min, the breathing rate at 60–100 breaths
per min and the temperature at 36–37 C.
MR imaging was performed with a 9.4 T small animal MR
scanner (Bruker BioSpin GmbH) equipped with a 35mm-diameter
quadrature birdcage RF coil (Rapid Biomedical, Rimpar, Germany).
Images were acquired using ECG triggering and respiratory gating
(Small Animal Instruments Inc., Stony Brook, NY, USA). To visualize
nanoparticle accumulation and washout, T1-weighted multi-slice
FLASH measurements were performed, with the following
parameters: TR 63ms, TE 1.8ms, a 60, NEX 6, FOV 3 3 cm2, matrix
192 192 and a slice stack of nine short-axis slices of 1mm
thickness, which covered the left ventricle from apex to base. For
measurement of cardiac function, single-slice cine FLASHmeasure-
ments were performed in which the following parameters were
adjusted: TR 7ms, a 15 , 1 slice of 1mm thickness and typically
13-15 cardiac frames. Nine short-axis slices from apex to base
and two long-axis slices were obtained. After MRI, mice were killed
by cervical dislocation and organs were excised, snap-frozen in
isopentane and cryosections of 5mm were prepared to study the
cellular distribution of the nanoparticles.
4.4. Confocal Laser Scanning Microscopy
Localization of NIR664–DSPE present in micelles and liposomes
was visualized by CLSM using a Zeiss LSMMETA system (Carl Zeiss
BV, Sliedrecht, the Netherlands). Sections were thawed and
covered with PBS and a cover glass. Excitation of NIR664 was
performed with a 633nm HeNe laser (5.0mW) and emission was
ﬁltered with a 680/60nm band-pass ﬁlter. Autoﬂuorescence of
heart tissue was excited with a 488nm Ar laser and the emission
was ﬁltered with a 525/50 nm band-pass ﬁlter. Cryosections of
animals injected with Gd–DTPA were used as negative controls.
To investigate co-localization of the nanoparticles, consecutive
sections were dual-stained for macrophages and leukocytes or
for vessels and extracellular matrix. Macrophages were
labeled with rat-anti-mouse CD68-FITC (4 mgml1, AbD Serotec,
Düsseldorf, Germany) and leukocytes with rat-anti-mouse
CD18-PE (2 mgml1, BioLegend, Uithoorn, the Netherlands).
Vessels were stained with rat-anti-mouse CD31-biotin (2mgml1,
Biolegend) coupled to streptavidin-Cy3 (1mgml1, BioLegend)
and the extracellular matrix was labeled with rabbit-anti-mouse
laminin (9mgml1, Sigma-Aldrich Chemie BV, Zwijndrecht, the
Netherlands) conjugated to goat-anti-rabbit Alexa488 (10mgml1,
Molecular Probes, Bleiswijk, the Netherlands). Coverglasses were
mounted with Mowiol. CLSM of stained macrophages (FITC) and
laminin (Alexa488) was performed with settings as described
above for autoﬂuorescence detection. Labeled leukocytes (PE)
and vessels (Cy3) were excited with a 543nm HeNe laser and
emission was ﬁltered with a 580/75nm band-pass ﬁlter. All images
were acquired with a 20 objective at an in-plane resolution of
0.31 0.31mm2, using the same settings for each ﬂuorophore.
CLSM images were visually scored for the localization of the nano-
particles and for co-localization of NIR signal and stainings.
4.5. Data Analysis and Statistics
T1 and T2 relaxation times for relaxivity measurements and blood
samples were determined with a custom-built ﬁtting program in
Mathematica 6 (Wolfram Research Europe, Oxfordshire, UK). For
the blood samples ΔR1 =R1,post R1,pre vs time after injection was
ﬁtted with a mono-exponential decay function in OriginPro 7.5
(OriginLab Corporation, Northampton, MA, USA) to determine
the circulation half-lives of the nanoparticles and Gd–DTPA.
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Global cardiac functional parameters were determined from the
single-slice cine FLASH measurements by semi-automatic analysis
with MRV FARM 2.0 software (Pie Medical Imaging, Maastricht,
the Netherlands). Cardiac functional parameters were not different
between the groups ofmice injectedwith different contrast agents
and therefore parameters were pooled per time point. This
software was also used to determine the regional wall thickening
in 20 segments per slice. In vivo T1-weighted FLASH images were
analyzed by manually drawing regions-of-interest (ROIs) in infarct
and remote ventricular tissue and in a noise-only region. For all
measurements, the infarct ROI was positioned in a region of
reduced wall thickening in the anterolateral left ventricular wall.
The remote ROI was placed in the septum. For mice measured at
week 1 or 2 after IR injury, infarct ROIs were carefully positioned
in the mid-myocardium, because histology conﬁrmed this as the
location of the infarct. Mean signal intensity (m) and standard
deviation (s) were determined for all ROIs. Subsequently, the
contrast-to-noise ratio (CNR) between infarct and remote ROIs
was calculated as: CNR= (minfarctmremote)/snoise. Finally, a running
average over three consecutive scans was applied.
All data are presented as mean standard error of the mean.
To test differences between nanoparticle characteristics Student’s
t-tests for independent samples were performed. One-way analysis
of variance with Bonferroni correction for multiple comparisons
was applied to test whether: (a) the CNR values for a speciﬁc
contrast agent changed signiﬁcantly in time and (b) the CNR values
of contrast agents were signiﬁcantly different at a speciﬁc time
point after injection. Values of p< 0.05 were considered signiﬁcant.
5. SUPPORTING INFORMATION
Supporting information can be found in the online version of
this article.
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